Stock listing
NASDAQ:LIMN Liminatus Pharma, Inc. Stock
Home listing (NASDAQ) of Liminatus Pharma, Inc.
Follow Liminatus Pharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LIMN
$2.52 USD -0.30 (-10.6%)
Close on Nov 2, 2026
- Day range
- $2.52 – $2.97 USDNov 2, 2026
- Volume
- 23,274 sharesNov 2, 2026
- Market cap
- $3.38M USDAt the close on Nov 2, 2026 · price × 1.34M shares outstanding
- 52-week range
- $2.52 – $141.50 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $122,633 USDMedian day 19,000 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LIMN · Home | $2.52 USD | -0.30 (-10.6%) | 23,274 | $2.97 | $2.97 | $2.52 | $2.82 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:LIMN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.52 | -0.30 | -10.6% | $2.97 | $2.97 | $2.52 | 23,274 | |
| $2.82 | -0.075 | -2.6% | $2.98 | $3.00 | $2.75 | 12,963 | |
| $2.895 | -0.025 | -0.9% | $3.06 | $3.14 | $2.81 | 28,056 | |
| $2.92 | +0.03 | +1.0% | $3.106 | $3.106 | $2.92 | 10,996 | |
| $2.89 | -0.27 | -8.5% | $3.01 | $3.01 | $2.785 | 24,113 | |
| $3.16 | +0.22 | +7.5% | $3.05 | $3.245 | $2.96 | 9,366 | |
| $2.94 | -0.17 | -5.5% | $3.10 | $3.17 | $2.905 | 20,700 | |
| $3.11 | -0.01 | -0.3% | $3.19 | $3.24 | $3.10 | 12,800 | |
| $3.12 | -0.10 | -3.1% | $3.26 | $3.455 | $3.04 | 118,800 | |
| $3.22 | +0.11 | +3.5% | $3.285 | $3.295 | $3.05 | 33,000 | |
| $3.11 | +0.07 | +2.3% | $3.175 | $3.285 | $3.08 | 33,000 | |
| $3.04 | -0.17 | -5.3% | $3.30 | $3.30 | $3.01 | 17,100 | |
| $3.21 | -0.04 | -1.2% | $3.295 | $3.364 | $3.21 | 15,800 | |
| $3.25 | -0.16 | -4.7% | $3.50 | $3.55 | $3.25 | 20,100 | |
| $3.41 | -0.04 | -1.2% | $3.625 | $3.625 | $3.41 | 13,700 | |
| $3.45 | -0.31 | -8.2% | $3.70 | $3.82 | $3.40 | 28,800 | |
| $3.76 | +0.07 | +1.9% | $3.555 | $3.81 | $3.555 | 16,900 | |
| $3.69 | -0.19 | -4.9% | $3.95 | $3.95 | $3.531 | 38,600 | |
| $3.88 | +0.18 | +4.9% | $3.701 | $3.89 | $3.65 | 22,900 | |
| $3.70 | -0.29 | -7.3% | $3.95 | $3.95 | $3.69 | 12,500 | |
| $3.99 | +0.09 | +2.3% | $3.80 | $4.08 | $3.80 | 18,000 | |
| $3.90 | +0.15 | +4.0% | $3.75 | $3.95 | $3.75 | 24,300 | |
| $3.75 | +0.02 | +0.5% | $3.74 | $3.86 | $3.65 | 28,200 | |
| $3.73 | -0.18 | -4.6% | $3.81 | $3.974 | $3.71 | 9,100 | |
| $3.91 | -0.36 | -8.4% | $4.23 | $4.31 | $3.83 | 38,400 | |
| $4.27 | +0.075 | +1.8% | $4.14 | $4.479 | $4.13 | 18,500 | |
| $4.195 | +0.015 | +0.4% | $4.26 | $4.34 | $4.091 | 17,700 | |
| $4.18 | +0.15 | +3.7% | $4.16 | $4.23 | $4.00 | 16,800 | |
| $4.03 | -0.04 | -1.0% | $4.05 | $4.137 | $3.90 | 17,200 | |
| $4.07 | +0.43 | +11.8% | $3.71 | $4.26 | $3.641 | 88,300 | |
| $3.64 | +0.16 | +4.6% | $3.68 | $3.72 | $3.56 | 16,000 | |
| $3.48 | +0.09 | +2.7% | $3.43 | $3.675 | $3.41 | 23,100 | |
| $3.39 | +0.06 | +1.8% | $3.35 | $3.44 | $3.345 | 8,900 | |
| $3.33 | -0.18 | -5.1% | $3.46 | $3.545 | $3.32 | 15,300 | |
| $3.51 | -0.01 | -0.3% | $3.50 | $3.58 | $3.415 | 14,000 | |
| $3.52 | +0.05 | +1.4% | $3.45 | $3.615 | $3.29 | 38,000 | |
| $3.47 | -0.16 | -4.4% | $3.63 | $3.675 | $3.46 | 31,400 | |
| $3.63 | +0.15 | +4.3% | $3.54 | $3.80 | $3.451 | 19,000 | |
| $3.48 | -0.14 | -3.9% | $3.60 | $3.65 | $3.48 | 20,800 | |
| $3.62 | -0.09 | -2.4% | $3.72 | $3.725 | $3.52 | 26,300 | |
| $3.71 | +0.01 | +0.3% | $3.70 | $3.82 | $3.65 | 23,200 | |
| $3.70 | -0.14 | -3.6% | $3.64 | $3.91 | $3.61 | 22,500 | |
| $3.84 | +0.195 | +5.3% | $3.86 | $4.00 | $3.70 | 31,600 | |
| $3.645 | -0.215 | -5.6% | $3.80 | $3.80 | $3.42 | 53,200 | |
| $3.86 | -0.37 | -8.7% | $4.24 | $4.26 | $3.80 | 51,300 | |
| $4.23 | -0.17 | -3.9% | $4.36 | $4.74 | $4.23 | 38,700 | |
| $4.40 | -0.01 | -0.2% | $4.37 | $4.88 | $4.37 | 51,800 | |
| $4.41 | -0.20 | -4.3% | $4.42 | $4.545 | $4.26 | 49,100 | |
| $4.61 | -0.06 | -1.3% | $4.64 | $4.84 | $4.35 | 73,212 | |
| $4.67 | -0.49 | -9.5% | $5.03 | $5.04 | $4.61 | 83,117 | |
| $5.16 | -0.47 | -8.3% | $5.53 | $5.876 | $5.15 | 117,361 | |
| $5.63 | +0.045 | +0.8% | $5.69 | $5.945 | $5.395 | 1,431 | |
| $5.585 | -0.915 | -14.1% | $5.535 | $5.90 | $5.25 | 1,882 | |
| $6.50 | -0.57 | -8.1% | $6.50 | $7.035 | $6.50 | 1,541 | |
| $7.07 | +0.07 | +1.0% | $6.575 | $7.475 | $6.50 | 1,641 | |
| $7.00 | -0.495 | -6.6% | $7.00 | $7.20 | $6.365 | 5,340 | |
| $7.495 | +2.07 | +38.2% | $7.385 | $9.20 | $6.705 | 222,938 | |
| $5.425 | -0.15 | -2.7% | $5.61 | $5.715 | $5.335 | 466 | |
| $5.575 | -0.275 | -4.7% | $5.955 | $6.24 | $5.125 | 1,035 | |
| $5.85 | +0.70 | +13.6% | $5.025 | $6.135 | $4.99 | 2,623 | |
| $5.15 | +0.205 | +4.1% | $4.945 | $5.35 | $4.945 | 1,009 | |
| $4.945 | -0.305 | -5.8% | $5.065 | $5.26 | $4.80 | 857 | |
| $5.25 | -0.66 | -11.2% | $5.35 | $5.745 | $5.155 | 1,114 | |
| $5.91 | +0.225 | +4.0% | $5.445 | $6.12 | $5.435 | 1,962 | |
| $5.685 | +0.535 | +10.4% | $5.20 | $6.355 | $5.20 | 8,824 |
- Ticker
- NASDAQ:LIMN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 29, 2026
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
Latest news
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
Sep 29, 2026
Closed $3.91 (-8.4%) on Sep 29, 2026
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
Aug 24, 2026
Closed $4.67 (-9.5%) on Aug 24, 2026
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
Aug 18, 2026
Closed $5.59 (-14.1%) on Aug 19, 2026
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
Aug 13, 2026
Closed $7.50 (+38.2%) on Aug 13, 2026
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
Jun 3, 2026
Closed $7.59 (-22.2%) on Jun 3, 2026
Liminatus Pharma Announces Nasdaq Delisting Notification
May 21, 2026
Closed $8.47 (-31.1%) on May 22, 2026
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
Mar 17, 2026
Closed $11.50 (-2.5%) on Mar 17, 2026
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
Feb 17, 2026
Closed $12.81 (-31.9%) on Feb 17, 2026
Decks
Investor Presentation (June 2025)
Investor deck · 22 slides · Jun 24, 2025
Liminatus Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 8 in the last 12 months · 18 in all · newest Sep 29, 2026 · oldest 2022
- Decks
- 1 deck · latest Jun 24, 2025
Where Liminatus Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LIMN · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LIMN | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Liminatus Pharma, Inc.